Macdonald R. Loch, CMO, reported a transaction classified as grant at Grace Therapeutics, Inc. involving 54690.000000 shares for an estimated $0.00. Reported holdings after the transaction were 54690.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Medical Officer
These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall ve…
0 other filings
0 recent txs